Youth Metacognitive Therapy (YoMeta): protocol for a single-blind randomised feasibility trial of a transdiagnostic intervention versus treatment as usual in 11-16-year-olds with common mental health problems

Adrian Wells, Karin Carter, Mark Hann, Gemma Shields, Paul Wallis, Beth Cooper, Lora Capobianco, Adrian Wells, Karin Carter, Mark Hann, Gemma Shields, Paul Wallis, Beth Cooper, Lora Capobianco

Abstract

Background: Mental health disorders in children and young people (CYP) are increasing but the provision of current evidence-based treatment for common mental health problems is limited. Treatment effects vary widely with no clear superiority of a single treatment approach. Further evaluation of contemporary and effective treatments in CYP is needed. Metacognitive therapy (MCT) has shown enhanced efficacy over 'gold standard' approaches in adult mental health, but so far has not been evaluated in a randomised trial of CYP. As such, we aim to assess the acceptability and feasibility of group-MCT for CYP with common mental health problems in comparison to usual treatment within Child and Adolescent Mental Health Services (CAMHS).

Method: YoMeta is a multicentre, two-arm, single-blind randomised feasibility trial comparing group-MCT to usual care in CYP with common mental health problems in CAMHS. CYP (target sample n = 100) with a common mental health problem will be recruited across at least three CAMHS services in the UK. Participants in the intervention arm will receive up to eight sessions of group-MCT delivered by a CAMHS mental health practitioner. The control arm will receive usual care in CAMHS which includes individual or group-based therapy. Feasibility will be assessed by the success of recruitment, retention, and data quality. Acceptability of the intervention will be assessed by the number of sessions attended and through qualitative interviews aimed at exploring CYP acceptability and understanding of the intervention. Symptoms of psychological distress will be assessed using the Revised Children Anxiety and Depression Scale (RCADS) at 20 weeks. We will also assess psychological well-being, symptoms of depression, metacognitive beliefs, quality of life, and measures to support economic evaluation (health status and health and social care use). Qualitative interviews will be conducted to understand practitioner's views on training and delivery of group-MCT.

Discussion: The trial is designed to evaluate the acceptability and feasibility of group-MCT for CYP with common mental health problems. Group-MCT may aid in improving access to treatment, reduce waiting times, and improve outcomes for CYP with common mental health disorders. The study will provide important information and data to evaluate future research potential and confirm sample size estimation for a definitive large-scale RCT to test the effectiveness and cost-effectiveness of group-MCT in CYP.

Trial registration: NCT05260060; ISCTRN18335255.

Keywords: Adolescents; Anxiety; CAMHS; Children; Depression; Mental health; Metacognitive therapy.

Conflict of interest statement

AW is the creator of Metacognitive Therapy and co-director of the MCT Institute.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
An overview of the trial design according to CONSORT guidelines
Fig. 2
Fig. 2
Schedule of enrolment, interventions, and assessments. Group-MCT, group-based metacognitive therapy; RCADS, Revised Children Anxiety and Depression Scale-Short version; SDQ, Strength and Difficulties Questionnaire; YoCAS-1, Youth Cognitive Attentional Syndrome-1; MCQ-A, Metacognition Questionnaire-Adolescent version; MFQ, Mood & Feelings Questionnaire; CHU-9D, Child Health Utility-9D; EQ-5D-Y; SUI, Health and Social Care Service-Use Interview; P, parent rated; YP, young person rated

References

    1. NHS Digital. Mental health of children and young people in England, 2017. 2018Available from:
    1. NHS Digital. Mental health of children and young people in England 2021 – wave 2 follow up to the 2017 survey. Mental Health of Children and Young People Surveys. 2021. Available from:
    1. Department of Health. Future in mind, promoting, protecting, and improving our children and young people’s mental health and well-being. 2015. Available from:
    1. Richards M, Abbott R. Childhood mental health and life chance in post-war Britain: insights from three national birth cohort studies. The Smith Institute. 2009. Available from:
    1. Office of National Statistics. Mental health of children and young people in Great Britain, 2004. Department of Health. 2004. Available from:
    1. Centre for Longitudinal Studies. Counting the true cost of childhood psychological problems in adult life. University College London. 2015. Available from:
    1. Children’s Commissioner. Children’s mental health services 2020/21. Children’s Commissioner. 2022. Available from:
    1. Children’s Commissioner. The state of children’s mental health services 2019/20. Children’s Commissioner. 2021. Available from:
    1. James A, Reardon T, Soler A, James G, Creswell C. Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev. 2020;11:CD013162. doi: 10.1002/14651858.CD013162.pub2.
    1. Cox G, Callahan P, Churchill R, Hunot V, Merry S, Parker A, et al. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents. Cochrane Database Syst Rev. 2012;(11) Available from. 10.1002/14651858.CD008324.pub2.
    1. O'Kearney R, Anstey K, von Sanden C, Hunt A. Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescents. Cochrane Database Syst Rev. 2006;(4) Available from. 10.1002/14651858.CD004856.pub2.
    1. Gillies D, Taylor F, Gray C, O'Brien L, D'Abrew N. Psychological therapies for the treatment of post-traumatic stress disorder in children and adolescents. Cochrane Database Syst Rev, Available from. 2013;(12). 10.1002/14651858.CD006726.pub2.
    1. Arnberg A, Öst L. CBT for children with depressive symptoms: a meta-analysis. Cogn Behav Therapy. 2013;43(4) Available from. 10.1080/16506073.2014.947316.
    1. Cox G, Callahan P, Churchill R, Hunot V, Merry S, Parker A, et al. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents. Cochrane Database Syst Rev. 2014;(11) Available from. 10.1002/14651858.CD008324.pub3.
    1. Zhou X, Teng T, Zhang Y, Del Giovane C, Furukawa T, Weisz J, et al. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis. Lancet Psychiatry. 2020;7(7) Available from. 10.1016/S2215-0366(20)30137-1.
    1. Wells A. Metacognitive therapy for anxiety and depression. New York: Guilford Press; 2009.
    1. Esbjørn B, Normann N, Christiansen B, Reinholdt-Dunne M. The efficacy of group metacognitive therapy for children (MCT-c) with generalized anxiety disorder: an open trial. J Anxiety Disord. 2018;53. 10.1016/j.janxdis.2017.11.002.
    1. Simons M, Kursawe A. Metacognitive therapy for posttraumatic stress disorder in youth: a feasibility study. Front Psychol. 2019;10. 10.3389/fpsyg.2019.00264.
    1. Simons M, Schneider S, Herpertz-Dahlmann B. Metacognitive therapy versus exposure and response prevention for pediatric obsessive-compulsive disorder. Psychother Psychosomatics. 2006;75(4):257–264. doi: 10.1159/000092897.
    1. Schulz K, Altman D, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340(mar23 1):c332. doi: 10.1136/bmj.c332.
    1. Eldridge S, Lancaster G, Campbell M, Thabane L, Hopewell S, Coleman C, et al. Defining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual framework. PLoS One. 2016;11(3):e0150205. doi: 10.1371/journal.pone.0150205.
    1. Chan A, Tetzlaff J, Altman D, Laupacis A, Gøtzsche P, Krleža-Jerić K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Int Med. 2013;158(3):200. doi: 10.7326/0003-4819-158-3-201302050-00583.
    1. Chan A, Tetzlaff J, Gotzsche P, Altman D, Mann H, Berlin J, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346(jan08 15):e7586. doi: 10.1136/bmj.e7586.
    1. Chorpita B, Yim L, Moffitt C, Umemoto L, Francis S. Assessment of symptoms of DSM-IV anxiety and depression in children: a revised child anxiety and depression scale. Behav Res Ther. 2000;38(8):835–855. doi: 10.1016/s0005-7967(99)00130-8.
    1. Ebesutani C, Reise S, Chorpita B, Ale C, Regan J, Young J, et al. The Revised Child Anxiety and Depression Scale-Short Version: scale reduction via exploratory bifactor modeling of the broad anxiety factor. Psychol Assess. 2012;24(4):833–845. doi: 10.1037/a0027283.
    1. Goodman R. The Strengths and Difficulties Questionnaire: a research note. J Child Psychol Psychiatry. 1997;38(5):581–586. doi: 10.1111/j.1469-7610.1997.tb01545.x.
    1. Muris P, Meesters C, van den Berg F. The Strengths and Difficulties Questionnaire (SDQ) Eur Child Adolesc Psychiatry. 2003;12(1):1–8. doi: 10.1007/s00787-003-0298-2.
    1. Cartwright-Hatton S, Mather A, Illingworth V, Brocki J, Harrington R, Wells A. Development and preliminary validation of the Meta-cognitions Questionnaire—Adolescent Version. J Anxiety Disord. 2004;18(3):411–422. doi: 10.1016/S0887-6185(02)00294-3.
    1. Myers S, Solem S, Wells A. The Metacognitions Questionnaire and its derivatives in children and adolescents: a systematic review of psychometric properties. Front Psychol. 2019;10. 10.3389/fpsyg.2019.01871.
    1. Costello E, Angold A. Scales to assess child and adolescent depression: checklists, screens, and nets. J Am Acad Child Adolesc Psychiatry. 1988;27(6):726–737. doi: 10.1097/00004583-198811000-00011.
    1. Thabrew H, Stasiak K, Bavin L, Frampton C, Merry S. Validation of the Mood and Feelings Questionnaire (MFQ) and Short Mood and Feelings Questionnaire (SMFQ) in New Zealand help-seeking adolescents. Int J Methods Psychiatr Res. 2018;27(3). 10.1002/mpr.1610.
    1. Wells A. Youth Cognitive Attentional Syndrome-1 (YoCAS-1) measure. University of Manchester; 2021.
    1. Stevens K. Valuation of the Child Health Utility 9D Index. PharmacoEconomics. 2012;30(8):729–747. doi: 10.2165/11599120-000000000-00000.
    1. Lindvall K, Vaezghasemi M, Feldman I, Ivarsson A, Stevens K, Petersen S. Feasibility, reliability and validity of the health-related quality of life instrument Child Health Utility 9D (CHU9D) among school-aged children and adolescents in Sweden. Health Qual Life Outcomes. 2021;19(1). 10.1186/s12955-021-01830-9.
    1. Wille N, Badia X, Bonsel G, Burström K, Cavrini G, Devlin N, et al. Development of the EQ-5D-Y: a child-friendly version of the EQ-5D. Qual Life Res. 2010;19(6):875–886. doi: 10.1007/s11136-010-9648-y.
    1. Kreimeier S, Greiner W. EQ-5D-Y as a health-related quality of life instrument for children and adolescents: the instrument’s characteristics, development, current use, and challenges of developing its value set. Value Health. 2019;22(1):31–37. doi: 10.1016/j.jval.2018.11.001.
    1. Hertzog M. Considerations in determining sample size for pilot studies. Res Nurs Health. 2008;31(2):180–191. doi: 10.1002/nur.20247.
    1. Lancaster G, Dodd S, Williamson P. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract. 2004;10(2):307–312. doi: 10.1111/j..2002.384.doc.x.
    1. RitchieJ LJ. Qualitative research practice. London: Sage Publications; 2003.
    1. Tansella M, Thornicroft G. Implementation science: understanding the translation of evidence into practice. Bri J Psychiatry. 2009;195(4):283–285. doi: 10.1192/bjp.bp.109.065565.
    1. Personal Social Services Research Unit (PSSRU). Unit costs of health and social care 2019. . 2019. Available from:
    1. England NHS, Improvement NHS. 2018/19 National Cost Collection Data Publication. London: NHS England and NHS Improvement; 2021.
    1. Leyfer O, Gallo K, Cooper-Vince C, Pincus D. Patterns and predictors of comorbidity of DSM-IV anxiety disorders in a clinical sample of children and adolescents. J Anxiety Dis. 2013;27(3):306–311. doi: 10.1016/j.janxdis.2013.01.010.
    1. NHS England. The five year forward view for mental health. Mental Health Taskforce 2016. Available from:
    1. Department of Health and Social Care and Department of Education. Transforming children and young people’s mental health provision: a green paper. 2017. Available from:
    1. Freeman A, Pretzer J, Fleming B, Simon K. Clinical applications of cognitive therapy. New York: Plenum; 2004.
    1. Ewing D, Monsen J, Thompson E, Cartwright-Hatton S, Field A. A meta-analysis of transdiagnostic cognitive behavioural therapy in the treatment of child and young person anxiety disorders. Behav Cogn Psychother. 2013;43(5):562–577. doi: 10.1017/S1352465813001094cc.
    1. Stewart J, Christner R, Freeman A, (ed). An introduction to cognitive behaviour group therapy with you. A handbook of cognitive-behaviour group therapy with children and adolescents. London: Routledge; 2007.
    1. Davies S, Quintner J, Parsons R, Parkitny L, Knight P, Forrester E, et al. Preclinic group education sessions reduce waiting times and costs at public pain medicine units. Pain Med. 2011;12(1):59–71. doi: 10.1111/j.1526-4637.2010.01001.x.
    1. Palay J, Wong J, Randall J, Sala T, Bolton J, Furer P, et al. Feasibility of large group cognitive behavioural therapy education classes for anxiety disorders. Eur J Person Centered Healthcare. 2018;6(2):274. doi: 10.5750/ejpch.v6i2.1454.
    1. Wells A. Breaking the cybernetic code: understanding and treating the human metacognitive control system to enhance mental health. Front Psychol. 2019;10:2621. doi: 10.3389/fpsyg.2019.02621.
    1. Wells A, Matthews G. Attention and emotion. A clinical perspective. Hove: Erlbaum; 1994.
    1. Wells A, Matthews G. Modelling cognition in emotional disorder: the S-REF model. Behav Res Ther. 1996;34(11-12):881–888. doi: 10.1016/S0005-7967(96)00050-2.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever